Oracle Just Sold $10 Billion of Stock at $116 a Share. Is the Stock a Buy at That Price?
Oracle (NYSE:ORCL) sold 86.2 million shares at $116 each, raising $9.9 billion, and issued $10 billion in notes with interest rates between 7% and 8.65%. The stock sale increases shares outstanding by 3%, while the notes add significant interest expense. Oracle plans no further stock or debt sales through fiscal 2030.
How this was made
The 30-second read
Why it matters
The capital raise expands Oracle's balance sheet and introduces dilution, but the cheap price may be viewed as a strategic advantage for long‑term investors.
Market read
A $10 billion equity raise is a material corporate action for a large‑cap tech company, likely influencing short‑term price dynamics and investor sentiment.
What to watch
Oracle's strong cash flow and record operating cash generation may offset dilution concerns over the medium term.
Background
Oracle announced a $10 billion equity raise and a $10 billion bond issuance, completing both on Nov 4. The equity portion was priced at $116 per share, about 11% below the prior close.
Ticker impact
Oracle sold 86.2 million new shares at $116, raising about $9.9 billion and added ~3% dilution to its share count.
likely modest downside pressure as investors price in the 3% dilution despite the low issue price.
A $10 billion equity raise is material; the issue price is below recent levels, suggesting the market may view it as a negative catalyst, but the cheap price may limit the sell‑off.
Market effects
The raise signals Oracle's confidence in its capital‑intensive cloud expansion, but may prompt peers to reassess financing strategies.
US tech sector may see slight pressure as a large-cap adds supply to the market.
Limited to investors tracking major US tech equities and capital‑raising trends.
Counterpoint
The low issue price could be a buying opportunity if the dilution impact is already priced in.
Key entities
- companyOracle
US‑listed cloud and enterprise software provider (ticker ORCL).
